May-Jun 2005
Novel Method for the Synthesis of 1,2,4-Oxadiazoles
701
3
(
-(2, 4-Dichlorophenyl)-5-(p-methoxyphenyl)-1,2,4-oxadiazole
3g).
This oxadiazole was prepared in the general way and has mp
Wyman, J. Med. Chem., 34, 2726 (1991).
[3] F. Watjen, R. Baker, M. Engelstoff, R. Herbert, A. MacLeod,
A. Knight, K. Merchant, J. Moseley, J. Saunders, C. J. Swain, E. Wong,
and J. P. Springer, J. Med. Chem., 32, 2282(1989).
1
1
7
7
39-141 °C (ethanol); H-NMR, δ (CDCl , TMS): 3.91 (s, 3H),
.04 (d, 2H, J=8.9 Hz), 7.40 (dd, 1H, J=8.4 Hz and J=2.0 Hz),
.57 (d, 1H, J=1.9 Hz), 8.00 (d, 1H, J=8.4 Hz), 8.21(d, 2H, J=8.8
H 3
[
4] F. I. Carroll, J. L. Gray, P. Abrahm, M. A. Kuzemko, A. H.
Lewin, J. W. Boja, and M. J. Kuhar, J. Med. Chem., 36, 2886 (1993).
5] G. D. Diana, D. L. Volkots, T. J. Nitz, T. R. Bailey, M. A.
[
1
3
Hz); C-NMR, δc (CDCl , TMS): 55.45, 114.50, 116.37,
1
1
Long, N. Vescio, S. Aldous, D. C. Pevear, and F. J. Dutko, J. Med. Chem.,
37, 2421 (1994).
[6] M. Ankersen, B. Peschke, B. S. Hansen, and T. K. Hansen,
Bioorg. Med. Chem. Lett., 7, 1293 (1997).
3
24.95, 127.21, 130.06, 130.72, 132.46, 134.25, 137.04, 163.28,
66.81, 175.15.
Anal. Calcd for C H Cl N O : C, 56.07; H, 3.11; N, 8.723.
1
5
10
2 2 2
[7] C. Chen, C. H. Senanayake, T. J. Bill, R. D. Larsen, T. R.
Found: C, 55.83; H, 3.18; N, 8.38.
Verhoeven, and P. J. Reider, J. Org. Chem., 59, 3738 (1994).
[8] R. J. Mathvink, A. M. Barritta, M. R. Candelore, M. A.
Cascieri, L. Deng, L. Tota, C. D. Strader, M. J. Wyvratt, M. H. Fisher, and
A. E. Weber, Bioorg. Med. Chem. Lett., 9, 1869 (1999).
3
-(4-Chlorophenylmethyl)-5-(4-nitrophenyl)-1, 2, 4-oxadiazole
(3h).
This oxadiazole was prepared in the general way and has mp
[
9] J. L. LaMattina and C. J. Mularski, J. Org. Chem., 49, 4800
(1984).
[10] G. B. Liang and X. Qian, Bioorg. Med. Chem. Lett., 9, 2101
(1999).
1
1
32-134 °C (ethanol); H-NMR, δ (CDCl , TMS): 4.13 (s, 2H),
H 3
7
.20-7.35(m, 4H), 8.27 (d, 2H, J=4.6 Hz), 8.34 (d, 2H, J=4.6 Hz);
1
3
C-NMR, δ (CDCl , TMS): 31.58, 124.21, 125.43, 128.54,
c
3
[11] G. B. Liang and D. D. Feng, Tetrahedron Lett., 37, 6627
1
29.18, 129.25, 130.41, 133.46, 150.12, 170.17, 173.75.
Anal. Calcd for C H ClN O : C, 57.06; H, 3.19; N, 13.31.
(
(
(
1996).
1
5
10
3 3
[12] A. G. Tyrkov, Khimiya i Khimicheskaya Tekhnologiya, 43, 73
Found: C, 57.40; H, 3.25; N, 13.20.
2000).
3
-(4-Chlorophenyl)-5-(4-nitrophenyl)-1,2,4-oxadiazole (3i).
[13] J. R. Young and R. J. DeVita, Tetrahedron Lett., 39, 3931
1998).
This oxadiazole was prepared in the general way and has mp
[14] R. Neidlein and L. Sheng, Syn. Commun., 25, 2379 (1995).
1
1
63-165 °C (ethanol); H-NMR, δ (CDCl , TMS): 7.54 (d, 2H,
H
3
[15] R. Neidlein and L. Sheng, J. Heterocyclic Chem., 33, 1943
1
3
J=5.8 Hz), 8.14 (d, 1H, J=5.8 Hz), 8.30-8.45 (m, 4H); C-NMR,
δ (CDCl , TMS): 124.31, 128.78, 129.14, 129.25, 129.36,
(1996).
c
3
[16] L. B. Clapp, Adv. Heterocycl. Chem., 20, 65 (1976).
1
29.47, 137.74, 150.20, 168.54, 173.75.
[17a] D. Korbonits and K. Horvath, Heterocycles, 37, 2051 (1994);
Anal. Calcd for C H ClN O : C, 55.73; H, 2.67; N, 13.93.
Found: C, 55.42; H, 2.87; N, 13.63.
[b] S. Chiou and H. J. Shine, J. Heterocyclic Chem., 26, 125 (1989); [c] L.
A. Kayukova, K. D. Praliev, I. S. Zhumadildaeva, and S. G. Klepikova,
Chem. Heterocycl. Compd., (NY), 35, 630 (1999); [d] N. S. Ooi and D. A.
Wilson, J. Chem. Soc., Perkin Trans. II, 1792 (1980); [e] K. E. Andersen,
B. F. Lundt, A. S. Joergensen, and C. Braestrup, Eur. J. Med. Chem., 31,
1
4
8
3 3
3
-Cyclohexyl-5-(4-nitrophenyl)-1,2,4-oxadiazole (3j).
This oxadiazole was prepared in the general way and has mp
4
17 (1996).
18] A. R. Gangloff, J. Litvak, J. E. J. Shelton, D. Sperandio, V. R.
Wang, and K. D. Rice, Tetrahedron Lett., 42, 1441 (2001).
19] N. Hebert, A. L. Hannah, and S. C. Sutton, Tetrahedron Lett.,
40, 8547 (1999).
[20] S. Caddick, Tetrahedron, 51, 10403 (1995).
1
1
(
1
1
01-103°C (ethanol); H-NMR, δ (CDCl , TMS): 1.26-1.50
H
3
[
m, 3H), 1.65 (dq, 2H, J=13 Hz and J=3 Hz), 1.71-1.78 (m, 1H),
.89 (td, 2H, J=13 Hz and J=3 Hz), 1.97-2.11 (m, 2H), 2.91 (tt,
H, J=13 Hz and J=3 Hz), 8.32 (d, 2H, J=8.9Hz), 8.39 (d, 2H,
[
1
3
J=8.9 Hz); C-NMR, δ (CDCl , TMS): 25.56, 25.73, 29.16,
c
3
+
4
3
5.26, 127.94, 128.28, 132.40, 136.07, 203.31; MS m/z: 228 (M ,
[21] V. Santagada, F. Frecentese, E. Perissutti, D. Cirillo, S.
Terracciano and G. Caloendo, Bioorg. Med. Chem. Lett., 14, 4491 (2004).
0), 125 (80), 123 (75), 109 (70), 105 (100), 83 (65).
[
22] M. D. Evans, J. Ring, A. Schoen, A. Bell, P. Edwards, D.
Berthelot, R. Nicewonger, and C. M. Baldino, Tetrahedron Lett., 44, 9337
2003).
[23] S. Rostamizadeh and S. A. G. Housaini, Tetrahedron Lett., 45,
753 (2004).
24] B. Oussaid, L. Moeini, B. Martin, D. Villemin, and B.
Garrigues, Synth. Commun., 25, 1451 (1995).
25] M. S. Balakrishna and B. Kaboudin, Tetrahedron Lett., 42,
127 (2001).
26a] B. Kaboudin and K. Navaee, Heterocycles, 55, 1443 (2001);
Anal. Calcd for C H N O . C, 61.53; H, 5.49; N, 15.38.
1
4 15 3 3
Found: C, 61.28; H, 5.65; N, 15.10.
(
Acknowledgement.
8
The authors thank the Institute for Advanced Studies in Basic
Sciences (IASBS) for supporting this work.
[
[
1
REFERENCES AND NOTES
[
[b] B. Kaboudin and K. Navaee, Heterocycles, 60, 2287 (2003).
[
1] H. J. Roth and A. Kleemann, Pharmaceutical Chemistry; Vol.
, Drug Synthesis. New York,: Wiley.
2] B. S. Orlek, F. E. Blaney, F. Brown, M. S. G. Clark, M. S.
Hadley, J. Hatcher, G. J. Riley, H. E. Rosenberg, H. J. Wadsworth, and P.
[27a] H. C. Ryu, Y. T. Hong, and S. K. Kang, Heterocycles, 54, 985
1
(2000); [b] C. L. Bell, C. N. Nambury, and L. Bauer, J. Org. Chem., 29,
2873 (1964); [c] F. Eloy and R. Lenaers, J. Org. Chem., 26, 155 (1961).
[28] D. Villemin and F. Caillot, Tetrahedron Lett., 42, 639 (2001).
[